Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2590c37e4b9dcbd4266ff8a3a9a67755 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22 |
filingDate |
2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90401cc857ac7c0acdc073e6b50a7a0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f307bc82bba22c86571238e0ed4565b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45bf191e970f08b46f4806e274527e08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f75ba6de24b95a296357a8ecf15acc0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f88de6522d80a8ebd9e82284c2ed4a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8107d86ff73526a8c9d76b464c03d9bd |
publicationDate |
2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2016333886-B2 |
titleOfInvention |
Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene |
abstract |
Disclosed herein are recombinant meganucleases engineered to recognize and cleave a recognition sequence present in the human T cell receptor alpha constant region gene. The present disclosure further relates to the use of such recombinant meganucleases in methods for producing genetically-modified eukaryotic cells. |
priorityDate |
2015-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |